Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 4Ovarian Neoplasms 3Stomach Neoplasms 2Solid Tumor 2Gastric Adenocarcinoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Two Different Treatment Methods 1Squamous Cell Carcinoma of Head and Neck 1Osteosarcoma 1Mucosal Melanoma 1Melanoma 1Immunotherapy Gastrict Cancer 1Immunotherapy 1HER-2 Negatived Gastric Cancer 1Carcinoma, Ovarian Epithelial 1Advanced Triple Negative Breast Cancer 1Advanced Metastatic Gastric Cancer 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Gastric Cancer 1Advanced Gastric Adenocarcinoma 1Advanced Esophagus Cancer 1Adenocarcinoma of Lung 1

Interventions

Pemetrexed 3Gefitinib 2Carboplatin 2icotinib 1endostar protein 1apatinib 1Platinum Compounds 1Endostatins 1Drug Therapy 1Cisplatin 1Bevacizumab 1Berberine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Adenocarcinoma of Lung × apatinib × Clear all
NCT03376737 2017-12-18

Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma

Henan Cancer Hospital

Phase 2 Unknown
120 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡